Chr. Hansen Holding A/S - Manager's transactions
November 09, 2020 09:38 ET
|
Chr. Hansen Holding A/S
Company annoucement no. 28/2020 November 3, 2020 For further information please contact: Martin Riise, Senior Director, Investor Relations, Tel: +45 5339 2250 Annika Stern, Investor Relations...
Manager's transactions
November 03, 2020 06:10 ET
|
Chr. Hansen Holding A/S
Company annoucement no. 27/2020November 3, 2020 For further information please contact:Martin Riise, Senior Director, Investor Relations, Tel: +45 5339 2250Annika Stern, Investor Relations Officer,...
Lise Mortensen assumes responsibility as new CFO
October 30, 2020 06:18 ET
|
Chr. Hansen Holding A/S
October 30, 2020 – announcement no. 26 Today, Lise Mortensen assumes the responsibility as Executive Vice President and CFO for Chr. Hansen Holding A/S and enters the Executive Board, replacing...
Notice to convene the Annual General Meeting 2020
October 29, 2020 06:05 ET
|
Chr. Hansen Holding A/S
Company announcement no. 25 The Annual General Meeting of Chr. Hansen Holding A/S will be held on Wednesday, November 25, 2020 at 4:00 p.m. CET at Søhuset Konferencecenter, Venlighedsvej 10, 2970...
Manager's transactions
October 09, 2020 07:58 ET
|
Chr. Hansen Holding A/S
Company annoucement no. 24/2020October 9, 2020 Purchase of sharesChr. Hansen Holding A/S has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions...
Chr. Hansen Holding A/S Full-year report - Statement of results 2019/20
October 08, 2020 02:02 ET
|
Chr. Hansen Holding A/S
Company Announcement No. 23/2020 CEO Mauricio Graber says: “2019/20 was a defining and extremely eventful year for Chr. Hansen. We launched our new 2025 Strategy to become a focused bioscience...
Chr. Hansen Holding A/S enters into a definitive agreement to divest its Natural Colors business to EQT
September 25, 2020 22:21 ET
|
Chr. Hansen Holding A/S
Chr. Hansen Holding A/S has today entered into an agreement to divest its Natural Colors business to the EQT IX Fund for a cash consideration of 800 EUR million on cash and debt free basis. The...
Chr. Hansen Holding A/S acquires Jennewein Biotechnologie GmbH to enter and lead the high-growth Human Milk Oligosaccharides market
September 22, 2020 06:06 ET
|
Chr. Hansen Holding A/S
COMPANY ANNOUNCEMENT NO.21/2020 Chr. Hansen Holding A/S (“Chr. Hansen”) has today entered into an agreement to acquire all of the shares of Jennewein Biotechnologie GmbH (“Jennewein”), which is a...
Chr. Hansen launches 2025 Strategy with the ambition to create a differentiated bioscience leader to improve food and health for a sustainable future
August 24, 2020 11:01 ET
|
Chr. Hansen Holding A/S
Company Announcement No. 20/2020 August 24, 2020 Please see the full announcement in the attached document. 2025 Strategy founded in strong purpose: “Grow a better world. Naturally”Exciting...
Chr. Hansen completes UAS Labs acquisition
July 28, 2020 01:29 ET
|
Chr. Hansen Holding A/S
Company announcement No. 19/2020 July 28, 2020 Chr. Hansen Holding A/S (“Chr. Hansen”) today announced that it has successfully completed the acquisition of UAS Laboratories LLC (“UAS...